Poster

Advantage Of Antibody Based Selectivity In The Purification Of Biologics

Source: Thermo Fisher Scientific

By Pim Hermans, Frank Detmers, Hendrik Adams, Orjana Terova and Jessica de Rooij, Thermo Fisher Scientific

Advances in bio-therapeutics are generating an increasing range of complex molecules that present unique and often complex purification challenges. By taking advantage of antibody based selectivity, Camelid heavy-chain antibody fragments (VHHs) have proven to be a reliable immuno-affinity chromatography (IAC) solution in the downstream process of biologics. ThermoScientific™ CaptureSelect™ affinity products and analytical tools are developed for the discovery and manufacturing of even the most demanding bio-therapeutics.The affinity resins provide high target purity in  a single step, independent of feedstock.

CAPTURESELECT TECHNOLOGY –UNIQUE AFFINITY PURIFICATION SOLUTION

  • Affinity through antibody selectivity: technology based on Camelidsingle domain [VHH] antibody fragments
  • Unique VHH screening technology to determine final resin properties such as target specificity, mild elution & ligand stability
  • Animal origin free production process (Saccharomyces Cerevisiae)
  • Technology used in commercial purification processes

VIEW THE POSTER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: